Correlation Between First Ship and Canopus BioPharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both First Ship and Canopus BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining First Ship and Canopus BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between First Ship Lease and Canopus BioPharma Incorporated, you can compare the effects of market volatilities on First Ship and Canopus BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in First Ship with a short position of Canopus BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of First Ship and Canopus BioPharma.

Diversification Opportunities for First Ship and Canopus BioPharma

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between First and Canopus is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding First Ship Lease and Canopus BioPharma Incorporated in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Canopus BioPharma and First Ship is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on First Ship Lease are associated (or correlated) with Canopus BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Canopus BioPharma has no effect on the direction of First Ship i.e., First Ship and Canopus BioPharma go up and down completely randomly.

Pair Corralation between First Ship and Canopus BioPharma

Assuming the 90 days horizon First Ship is expected to generate 32.49 times less return on investment than Canopus BioPharma. But when comparing it to its historical volatility, First Ship Lease is 13.54 times less risky than Canopus BioPharma. It trades about 0.04 of its potential returns per unit of risk. Canopus BioPharma Incorporated is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  3.00  in Canopus BioPharma Incorporated on November 8, 2024 and sell it today you would lose (2.99) from holding Canopus BioPharma Incorporated or give up 99.67% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy99.19%
ValuesDaily Returns

First Ship Lease  vs.  Canopus BioPharma Incorporated

 Performance 
       Timeline  
First Ship Lease 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days First Ship Lease has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, First Ship is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.
Canopus BioPharma 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Canopus BioPharma Incorporated are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite somewhat inconsistent forward indicators, Canopus BioPharma sustained solid returns over the last few months and may actually be approaching a breakup point.

First Ship and Canopus BioPharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with First Ship and Canopus BioPharma

The main advantage of trading using opposite First Ship and Canopus BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if First Ship position performs unexpectedly, Canopus BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Canopus BioPharma will offset losses from the drop in Canopus BioPharma's long position.
The idea behind First Ship Lease and Canopus BioPharma Incorporated pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios